TE_15535
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | HERVE |
|---|---|
| TE superfamily | ERV1 |
| TE order | LTR |
| Gene | -, ENSG00000287860 |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 0.06 |
| Counts of samples | TCGA_tumor:4; TCGA_normal:0; GTEx:101 |
| TSS | chr7(-):6955572 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_15535.1 | ENSG00000287860 | Chimeric | Non-coding | Non-coding | chr7(-):6953229,6953249,6953826,6954449,6955440,6955573 |
| teRNA_15535.2 | - | Intergenic | Non-coding | Non-coding | chr7(-):6953247,6953267,6953826,6954449,6955440,6955573 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
